Drug Eluting Stent (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI102612

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Cardiovascular Diseases, By Key Regions/ Key Countries, 2025
2. New Product Launches, By Key Market Players
3. Key Industry Developments, Such as Mergers & Acquisitions
4. Pricing Analysis, By Key Brands, Key Players/ Key Regions
Global Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
  1. Boston Scientific Corporation
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  2. Abbott
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  3. Medtronic
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  4. Biotronik
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  5. Terumo Corporation
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  6. MicroPort Scientific Corporation
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  7. Other Prominent Players
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
Strategic Recommendations

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Cardiovascular Diseases, By Key Regions/ Key Countries, 2025
2. New Product Launches, By Key Market Players
3. Key Industry Developments, Such as Mergers & Acquisitions
4. Pricing Analysis, By Key Brands, Key Players/ Key Regions
Global Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Coronary Stenting
  2. Peripheral Stenting
3. Market Analysis, Insights and Forecast – By Scaffold
  1. Cobalt-Chromium
  2. Platinum-Chromium
  3. Nitinol
  4. Others
4. Market Analysis, Insights and Forecast – By Drug
  1. Sirolimus
  2. Paclitaxel
  3. Zotarolimus
  4. Everolimus
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
  1. Boston Scientific Corporation
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  2. Abbott
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  3. Medtronic
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  4. Biotronik
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  5. Terumo Corporation
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  6. MicroPort Scientific Corporation
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  7. Other Prominent Players
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
Strategic Recommendations

Read Less

List of Figures

Figure 1: Global Drug Eluting Stents (DES) Market Revenue Breakdown (US$ Mn, %) by Region, 2025 & 2034

Figure 2: Global Drug Eluting Stents (DES) Market Value Share (%), by Type, 2025 & 2034

Figure 3: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Coronary Stenting, 2021-2034

Figure 4: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Peripheral Stenting, 2021-2034

Figure 5: Global Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2025 & 2034

Figure 6: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Cobalt-Chromium, 2021-2034

Figure 7: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Platinum-Chromium, 2021-2034

Figure 8: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Nitinol, 2021-2034

Figure 9: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Others, 2021-2034

Figure 10: Global Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2025 & 2034

Figure 11: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Sirolimus, 2021-2034

Figure 12: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Paclitaxel, 2021-2034

Figure 13: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Zotarolimus, 2021-2034

Figure 14: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Everolimus, 2021-2034

Figure 15: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Mod5, 2021-2034

Figure 16: Global Drug Eluting Stents (DES) Market Value Share (%), by End User, 2025 & 2034

Figure 17: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Hospitals, 2021-2034

Figure 18: Global Drug Eluting Stents (DES) Market Forecast (US$ Mn), by Specialty Clinics, 2021-2034

Figure 19: Global Drug Eluting Stents (DES) Market Value (US$ Mn), by Region, 2025 & 2034

Figure 20: North America Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2025 & 2034

Figure 21: North America Drug Eluting Stents (DES) Market Value Share (%), by Type, 2025

Figure 22: North America Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2025 & 2034

Figure 23: North America Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2025

Figure 24: North America Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2025 & 2034

Figure 25: North America Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2025

Figure 26: North America Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2025 & 2034

Figure 27: North America Drug Eluting Stents (DES) Market Value Share (%), by End User, 2025

Figure 28: North America Drug Eluting Stents (DES) Market Value (US$ Mn), By Country, 2025 & 2034

Figure 29: North America Drug Eluting Stents (DES) Market Value Share (%), By Country, 2025

Figure 30: Europe Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2025 & 2034

Figure 31: Europe Drug Eluting Stents (DES) Market Value Share (%), by Type, 2025

Figure 32: Europe Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2025 & 2034

Figure 33: Europe Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2025

Figure 34: Europe Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2025 & 2034

Figure 35: Europe Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2025

Figure 36: Europe Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2025 & 2034

Figure 37: Europe Drug Eluting Stents (DES) Market Value Share (%), by End User, 2025

Figure 38: Europe Drug Eluting Stents (DES) Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034

Figure 39: Europe Drug Eluting Stents (DES) Market Value Share (%), By Country/ Sub-region, 2025

Figure 40: Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2025 & 2034

Figure 41: Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), by Type, 2025

Figure 42: Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2025 & 2034

Figure 43: Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2025

Figure 44: Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2025 & 2034

Figure 45: Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2025

Figure 46: Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2025 & 2034

Figure 47: Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), by End User, 2025

Figure 48: Asia Pacific Drug Eluting Stents (DES) Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034

Figure 49: Asia Pacific Drug Eluting Stents (DES) Market Value Share (%), By Country/ Sub-region, 2025

Figure 50: Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2025 & 2034

Figure 51: Latin America Drug Eluting Stents (DES) Market Value Share (%), by Type, 2025

Figure 52: Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2025 & 2034

Figure 53: Latin America Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2025

Figure 54: Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2025 & 2034

Figure 55: Latin America Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2025

Figure 56: Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2025 & 2034

Figure 57: Latin America Drug Eluting Stents (DES) Market Value Share (%), by End User, 2025

Figure 58: Latin America Drug Eluting Stents (DES) Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034

Figure 59: Latin America Drug Eluting Stents (DES) Market Value Share (%), By Country/ Sub-region, 2025

Figure 60: Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), by Type, 2025 & 2034

Figure 61: Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), by Type, 2025

Figure 62: Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), by Scaffold, 2025 & 2034

Figure 63: Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), by Scaffold, 2025

Figure 64: Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), by Drug, 2025 & 2034

Figure 65: Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), by Drug, 2025

Figure 66: Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), by End User, 2025 & 2034

Figure 67: Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), by End User, 2025

Figure 68: Middle East & Africa Drug Eluting Stents (DES) Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034

Figure 69: Middle East & Africa Drug Eluting Stents (DES) Market Value Share (%), By Country/ Sub-region, 2025

Figure 70: Global Drug Eluting Stents (DES) Market Share (%), By Company, 2025

List of Tables

Table 1: Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2021–2034

Table 2: Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2021–2034

Table 3: Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2021–2034

Table 4: Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2021–2034

Table 5: Global Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Region, 2021-2034

Table 6: North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034

Table 7: North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2021-2034

Table 8: North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2021-2034

Table 9: North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2021-2034

Table 10: North America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country, 2021-2034

Table 11: Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034

Table 12: Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2021-2034

Table 13: Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2021-2034

Table 14: Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2021-2034

Table 15: Europe Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

Table 16: Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034

Table 17: Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2021-2034

Table 18: Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2021-2034

Table 19: Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2021-2034

Table 20: Asia Pacific Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034

Table 22: Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2021-2034

Table 23: Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2021-2034

Table 24: Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2021-2034

Table 25: Latin America Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

Table 26: Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034

Table 27: Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Scaffold, 2021-2034

Table 28: Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by Drug, 2021-2034

Table 29: Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, by End User, 2021-2034

Table 30: Middle East & Africa Drug Eluting Stents (DES) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 145

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com